Spurned By NICE On Avastin In Bowel Cancer, Roche Looks To U.K. Cancer Drugs Fund

 
• By The Pink Sheet Daily

NICE's definitive decision against Avastin in bowel cancer forces Roche to turn to Cancer Drugs Fund.

More from Archive

More from Pink Sheet